"Keratolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
| Descriptor ID |
D007641
|
| MeSH Number(s) |
D27.505.954.444.400
|
| Concept/Terms |
Keratolytic Agents- Keratolytic Agents
- Agents, Keratolytic
- Skin-Peeling Agents
- Agents, Skin-Peeling
- Skin Peeling Agents
- Desquamating Agents
- Agents, Desquamating
|
Below are MeSH descriptors whose meaning is more general than "Keratolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Keratolytic Agents".
This graph shows the total number of publications written about "Keratolytic Agents" by people in this website by year, and whether "Keratolytic Agents" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 3 | 1 | 4 |
| 1997 | 2 | 0 | 2 |
| 1998 | 2 | 0 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 4 | 0 | 4 |
| 2006 | 2 | 1 | 3 |
| 2008 | 4 | 0 | 4 |
| 2009 | 1 | 2 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 3 | 5 |
| 2012 | 3 | 1 | 4 |
| 2013 | 1 | 1 | 2 |
| 2015 | 2 | 2 | 4 |
| 2016 | 3 | 0 | 3 |
| 2017 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 2 | 2 |
Below are the most recent publications written about "Keratolytic Agents" by people in Profiles.
-
The status of treatment for plantar warts in 2021: No definitive advancements in decades for a common dermatology disease. Clin Dermatol. 2021 Jul-Aug; 39(4):688-694.
-
Subcorneal pustular dermatosis associated with IgG monoclonal gammopathy of undetermined significance. Dermatol Online J. 2021 Apr 15; 27(4).
-
New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis. J Drugs Dermatol. 2020 Jun 01; 19(6):602-610.
-
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020 May 19; 323(19):1945-1960.
-
Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population J Drugs Dermatol. 2019 Sep 01; 18(9):910-916.
-
Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a preadolescent population. Pediatr Dermatol. 2019 Mar; 36(2):193-199.
-
Pharmacokinetics of tazarotene and acitretin in psoriasis. Expert Opin Drug Metab Toxicol. 2018 Sep; 14(9):919-927.
-
Atopic dermatitis: skin care and topical therapies. Semin Cutan Med Surg. 2017 Sep; 36(3):104-110.
-
Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study. J Am Acad Dermatol. 2016 Nov; 75(5):1068-1071.
-
Uremic pruritus treated successfully with the Goeckerman Program. Dermatol Online J. 2016 Aug 15; 22(8).